Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:30 pm Sale | 2021-12-31 | 13G | Annexon, Inc. ANNX | Novartis Bioventures Ltd | 910,747 2.370% | -1,196,497 (-56.78%) | Filing History |
| 2022-02-10 11:16 am Purchase | 2022-02-09 | 13G | Annexon, Inc. ANNX | PICTET ASSET MANAGEMENT SA | 58,684 5.630% | 58,684 (New Position) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Annexon, Inc. ANNX | FMR LLC | 1,340,027 3.491% | -860,859 (-39.11%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Annexon, Inc. ANNX | BlackRock Inc. BLK | 2,614,591 6.800% | 127,258 (+5.12%) | Filing History |
| 2021-11-19 06:45 am Sale | 2021-11-04 | 13G | Annexon, Inc. ANNX | New Enterprise Associates 15 L.P. | 0 0.000% | -2,495,687 (Position Closed) | Filing History |
| 2021-08-27 4:50 pm Sale | 2021-08-18 | 13D | Annexon, Inc. ANNX | Blackstone Holdings II L.P. | 1,820,423 4.700% | -910,212 (-33.33%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Citadel Advisors LLC | 2,136,115 5.600% | 15,782 (+0.74%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group, LLC | 3,448,030 9.040% | 3,448,030 (New Position) | Filing History |
| 2021-02-16 3:21 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund, L.P. | 2,940,627 7.700% | 2,940,627 (New Position) | Filing History |
| 2021-02-12 6:42 pm Sale | 2020-12-31 | 13G | Annexon, Inc. ANNX | Zone II Healthcare Holdings, LLC | 1,557,261 4.100% | -260,000 (-14.31%) | Filing History |
| 2021-02-12 4:05 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Eventide Asset Management, LLC | 2,004,616 5.300% | 2,004,616 (New Position) | Filing History |
| 2021-02-12 1:29 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | New Enterprise Associates 15 L.P. | 2,495,687 6.500% | 2,495,687 (New Position) | Filing History |
| 2021-02-12 07:00 am Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Satter Muneer A | 1,954,978 5.100% | 1,954,978 (New Position) | Filing History |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | Annexon, Inc. ANNX | FMR LLC | 2,200,886 5.767% | 2,200,886 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | BlackRock Inc. BLK | 2,487,333 6.500% | 2,487,333 (New Position) | Filing History |
| 2021-01-29 09:07 am Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Novartis Bioventures Ltd | 2,107,244 5.520% | 2,107,244 (New Position) | Filing History |